Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$365K Sell
3,022
-11
-0.4% -$1.27K 0.03% 130
2025
Q4
$326K Buy
3,033
+745
+33% +$69.9K 0.03% 140
2025
Q3
$204K Buy
2,288
+437
+24% +$36K 0.02% 163
2025
Q2
$153K Buy
1,851
+210
+13% +$16.7K 0.02% 159
2025
Q1
$147K Sell
1,641
-68
-4% -$6.35K 0.02% 155
2024
Q4
$170K Sell
1,709
-57
-3% -$5.88K 0.02% 147
2024
Q3
$201K Sell
1,766
-237
-12% -$28.2K 0.02% 149
2024
Q2
$248K Sell
2,003
-3,503
-64% -$451K 0.03% 139
2024
Q1
$727K Sell
5,506
-890
-14% -$110K 0.06% 105
2023
Q4
$658K Hold
6,396
0.07% 103
2023
Q3
$658K Buy
6,396
+230
+4% +$24.8K 0.07% 103
2023
Q2
$711K Hold
6,166
0.08% 93
2023
Q1
$656K Sell
6,166
-40
-0.6% -$4.32K 0.08% 95
2022
Q4
$689K Buy
6,206
+2,902
+88% +$297K 0.09% 91
2022
Q3
$285K Buy
+3,304
New +$295K 0.04% 118
2020
Q2
Sell
-559
Closed -$41K 167
2020
Q1
$41K Sell
559
-1,153
-67% -$90.6K 0.01% 101
2019
Q4
$149K Buy
1,712
+1,083
+172% +$89K 0.03% 63
2019
Q3
$51K Sell
629
-11
-2% -$882 0.01% 96
2019
Q2
$51K Buy
640
+90
+16% +$6.89K 0.01% 91
2019
Q1
$44K Buy
550
+26
+5% +$1.95K 0.01% 92
2018
Q4
$38K Buy
+524
New +$37K 0.01% 98

Other funds holding MRK

Salomon & Ludwin's MRK Position: Q1 2026 in Review

Salomon & Ludwin reduced its Merck (MRK) stake by 0.36% in Q1 2026, selling an estimated $1.27K and leaving 3,022 shares worth $365K. The position accounts for 0.03% of the portfolio, ranked #130.

Salomon & Ludwin first reported a position in MRK in Q4 2018 and has held it in 21 quarters since. The position peaked at $727K in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Salomon & Ludwin held 3,022 shares of Merck worth $365K as of Q1 2026.
  • Salomon & Ludwin sold 11 Merck shares in Q1 2026, an estimated $1.27K.
  • Merck made up 0.03% of Salomon & Ludwin's portfolio in Q1 2026, its #130 holding.
  • Salomon & Ludwin first reported a position in Merck in Q4 2018 and has held it in 21 quarters since.
  • Salomon & Ludwin's Merck position peaked at $727K in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.